FMR1 and cholangiocarcinoma: In addition to gastric cancer, FMR1 was markedly upregulated in cancers such as cholangiocarcinoma (CHOL) and colon adenocarcinoma (COAD), whereas it was downregulated in cancers including glioblastoma multiforme (GBM), kidney renal clear cell carcinoma (KIRC), and prostate adenocarcinoma (PRAD), among others..